<DOC>
	<DOCNO>NCT02067936</DOCNO>
	<brief_summary>The investigator study whether four equipotent combination propofol remifentanil ( predict interaction model `` tolerance laryngoscopy '' ) result identical haemodynamic condition , independent relative different balance concentration propofol remifentanil .</brief_summary>
	<brief_title>Walking Isobole Drug Interaction</brief_title>
	<detailed_description>In anesthesia , synergistic interaction hypnotic opioids apply daily give adequate anesthesia analgesia significantly low dos compare one need one drug give reach effect . A lot research do quantify interaction focus desired effect ( Tolerance laryngoscopy , tolerance shake shout etc ... ) , simultaneous interaction unwanted side effect less well describe . The response surface model Bouillon et al . model predict combination propofol remifentanil effect-site concentration lead equipotent desired effect . Due availability model , anesthesiologist could use knowledge interaction target specific effect accurately , use predefined equipotent combination drug : instance , desirable 90 % probability tolerance laryngoscopy ( TOL90 ) population reach either high propofol/low remifentanil combination , equally well low propofol-high remifentanil combination . However , time know whether combination propofol remifentanil favorable hemodynamic stability compare equipotent combination . The researcher study want determine whether equipotent combination remifentanil propofol ( deliberately select evoke 90 % probability `` tolerance laryngoscopy '' ) , result different effect undesired side effect anesthetic , hemodynamic instability ( hypotension , change heart rate cardiac output ) , decrease cerebral tissue oxygenation ( measure near infrared spectroscopy ) .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>Written inform consent General anesthesia require procedure Age : 18 year old American Society Anesthesiologists ( ASA ) physical status I III Refusal participate study Contraindications use propofol remifentanil BMI &gt; 35 kg/m2 Central nervous system disorder ( i.e . cerebrovascular accident , dementia , seizure , psychiatric disorder ) Relevant hepatic disease ( Child B high ) Regular use medication affect central nervous system ( i.e . benzodiazepine , antidepressant , antipsychotic , antiepileptic drug ) Use alphaagonists betablockers Overt sign alcohol abuse Use preoperative benzodiazepine ( day study ) Beta blocker eye drip Overt sign Drugs abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>